Immunological therapy of sepsis: experimental therapies

[41] ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) : 1627 - 1633

[42] MENINGOCOCCEMIA AND PURPURA FULMINANS IN ADULTS - ACUTE DEFICIENCIES OF PROTEIN-C AND PROTEIN-S AND EARLY TREATMENT WITH ANTITHROMBIN-III CONCENTRATES [J]. INTENSIVE CARE MEDICINE, 1990, 16 (02) : 121 - 124

[43] INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 547 - 550

[44] GIRARDIN E, 1992, J INFECT DIS, V165, P695, DOI 10.1093/infdis/165.4.695

[45] Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis [J]. LANCET, 1997, 350 (9089) : 1439 - 1443

[46] ADMINISTRATION OF LOW-DOSE ENDOTOXIN TO HEALTHY HUMANS INCREASES C5A BINDING TO CIRCULATING NEUTROPHILS [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) : 480 - 482

[47] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08): : 1097 - 1102

[48] An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyI-L-arginine hydrochloride (546C88), in patients with septic shock [J]. CRITICAL CARE MEDICINE, 1999, 27 (05) : 913 - 922

[49] p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E(2) biosynthesis stimulated by interleukin-1 beta [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) : 8083 - 8089

[50] Harada A, 1996, MOL MED TODAY, V2, P482

[41] ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) : 1627 - 1633

[42] MENINGOCOCCEMIA AND PURPURA FULMINANS IN ADULTS - ACUTE DEFICIENCIES OF PROTEIN-C AND PROTEIN-S AND EARLY TREATMENT WITH ANTITHROMBIN-III CONCENTRATES [J]. INTENSIVE CARE MEDICINE, 1990, 16 (02) : 121 - 124

[43] INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 547 - 550

[44] GIRARDIN E, 1992, J INFECT DIS, V165, P695, DOI 10.1093/infdis/165.4.695

[45] Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis [J]. LANCET, 1997, 350 (9089) : 1439 - 1443

[46] ADMINISTRATION OF LOW-DOSE ENDOTOXIN TO HEALTHY HUMANS INCREASES C5A BINDING TO CIRCULATING NEUTROPHILS [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) : 480 - 482

[47] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08): : 1097 - 1102

[48] An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyI-L-arginine hydrochloride (546C88), in patients with septic shock [J]. CRITICAL CARE MEDICINE, 1999, 27 (05) : 913 - 922

[49] p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E(2) biosynthesis stimulated by interleukin-1 beta [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) : 8083 - 8089

[50] Harada A, 1996, MOL MED TODAY, V2, P482